| Write You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > How To Find Tomorrow's Winners |
|
Write You - How To Find Tomorrow's Winners
Don't waste your time and energy worrying about the big ones that got away,
invest these two pre According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product cious commodities to find tomorrow's winners. If you are hunting for individual stocks or sectors ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in begin with an assessment
of what people are going to need more of in coming years and try to fi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. d those
companies that are leaders or trying to become leaders in those fields. Some investors here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe o not wish to mess with their portfolios and just wish to try a
small short-term bet on somethin d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro and that is perfectly okay (and probably prudent).
The important thing is to distinguish betwee ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc short-term speculations and long-term
investments, because your objectives with the two will pr easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi bably be different. Your long-term investments could probably endure a 20% drop in value if you a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e
holding them for 10 years or longer. A short-term speculative play with a loss of
10% might and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e too much of a loss because the idea of these plays is to get in and
out very quickly. And if y ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi u take hits of 30-40% it won't be long before your
speculative capital is gone. Now is the time ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a to think about the next big market plunge because sooner or later
we know it has to hit. Some o dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod the big name growth stocks may seem too high today,
but if they begin to head lower for whateve cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin reason you should begin to consider
at what price level you might wish to enter them and commit tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen to buying them. And keep in mind that some people cannot make investment decisions because they t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel think they can never do enough research in order to be sure about something.
Now is the time to ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ace reality: we can never be absolutely sure, all of our
investments involve some degree of chan y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e. As long as something does not involve putting your entire investment plan in jeopardy, you m . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ght just want to go ahead and play one of your hunches. Often
times your instincts are right and elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip when they aren't, you can learn something
that may help you make smarter decisions down the road tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Advertising Balloon Signage for Promotion Are You Using The Four Letter Word?
|